MedTrace Logo

Genomic Predictors of Papillary Microcarcinoma Disease Progression

NCT02363595 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2026-03-12

No results posted yet for this study

Summary

The study is being done to answer the following question: What are the specific clinical and molecular features that will help us predict which small thyroid cancers are likely to grow and be problematic?

Therefore, the purpose of this study is to identify specific clinical and molecular characteristics that are predictive of tumor progression in small thyroid cancers.

Conditions

  • Papillary Microcarcinoma

Sponsors & Collaborators

Principal Investigators

  • Robert Tuttle, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02363595 on ClinicalTrials.gov